NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Authors McKenna, Avery, author Remove constraint Authors: McKenna, Avery, author

Search Results

1. AMX0035 and oral edaravone for amyotrophic lateral sclerosis: final evidence report

2. Novel agents to prevent chemotherapy-induced neutropenia and other myelosuppressive effects: revised evidence report

3. Unsupported price increase report: 2020 assessment

4. Nadofaragene firadenovec and oportuzumab monatox for BCG-unresponsive, non-muscle invasive bladder cancer: effectiveness and value : final report

5. Observational real-world evidence update: prophylaxis of hereditary angioedema with Takhzyro and C1 inhibitors : effectiveness and value

6. Aducanumab for Alzheimer’s disease: effectiveness and value

7. Gene therapies for sickle cell disease: final evidence report

8. Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: effectiveness and value : final evidence report

9. Special assessment of outpatient treatments for COVID-19: nirmatrelvir/ritonavir (Paxlovid) health-benefit price benchmark update